Physician profile
Aristide Burducea
NPI 1891959052
$5,499.20
in general payments reported to CMS, 2019-2025
18 companies · $949 in 2025
The $949 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,385 · 2020: $278 · 2021: $510 · 2022: $637 · 2023: $1,477 · 2024: $265 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897 · Travel and Lodging: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.59 |
| Travel and Lodging | $793.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,486.76 | 2019-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Infinion 16 |
| Stryker Corporation | $811.81 | 2023-2025 | Spinejack, Optablate |
| Nevro Corp. | $436.50 | 2022 | |
| Zynex Medical, INC. | $402.41 | 2025 | Nexwave |
| Abbott Laboratories | $310.48 | 2020-2025 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $248.77 | 2024-2025 | |
| Relievant Medsystems, INC. | $246.91 | 2023 | Intracept |
| Forte Bio-Pharma LLC | $182.15 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Vertos Medical, INC. | $81.83 | 2024 | Mild Device Kit |
| Valinor Pharma, LLC | $63.53 | 2023-2025 | Movantik |
| Kowa Pharmaceuticals America, INC. | $63.46 | 2023 | Seglentis |
| Medtronic, INC. | $48.07 | 2024-2025 | Synchromedii, Inceptiv |
| Spinal Elements, INC. | $29.61 | 2025 | |
| Protega Pharmaceutials INC | $20.45 | 2025 | Roxybond |
| Zimmer Biomet Holdings, INC. | $18.89 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $18.62 | 2023 | Iovera, Zilretta |
| Horizon Therapeutics Plc | $17.15 | 2021 | |
| Medtronic USA, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aristide Burducea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.